Colon News and Research

RSS

Exercise may reduce colorectal cancer risk after weight loss

New research suggests that exercise is a key factor in reducing colorectal cancer risk after weight loss. According to the study, physical activity causes beneficial changes in the bone marrow. The study is published ahead of print in the American Journal of Physiology--Endocrinology and Metabolism.

13 Dec 2018

Disrupted biological clock can contribute to onset of diseases, USC study shows

USC scientists report that a novel time-keeping mechanism within liver cells that helps sustain key organ tasks can contribute to diseases when its natural rhythm is disrupted.

11 Dec 2018

Novel personalized medicine tool for assessing inherited colorectal cancer syndrome risk developed

An international team of researchers led by Huntsman Cancer Institute at the University of Utah has developed, calibrated, and validated a novel tool for identifying the genetic changes in Lynch syndrome genes that are likely to be responsible for causing symptoms of the disease.

10 Dec 2018

Study: Patients with cancer have worse outcomes after heart procedure

Research led by Keele University suggests that patients with cancer who undergo a common heart procedure have worse short-term clinical outcomes compared to non-cancer patients, in the largest study undertaken to date.

30 Nov 2018

Researchers reveal how some cancers trick healthy cells into protecting tumors

Many factors affect cancer treatment outcome, such as the size and location of the tumor, availability of effective treatments, and timing of intervention. But some cancers are so aggressive that outcome is poor, even after early diagnosis and chemotherapy.

30 Nov 2018

Restricting cancer metabolism could make oncolytic viruses more effective at attacking tumors

Restricting the ability of cancer cells to metabolise sugar could make oncolytic viruses more effective at attacking them, suggests a study published today in the journal Cancer Research.

29 Nov 2018

CytoReason announces publication of new model for translating data from mouse models to human disease

CytoReason, developer of the world's first machine learning platform for human immune system cell-level simulation, today announces publication of a groundbreaking new model for translating data from mouse models to human disease.

27 Nov 2018

Researchers find link between inflammatory markers and tumor aggressiveness

Researchers at University Putra Malaysia found a relationship between some markers of inflammation in the body and the aggressiveness of certain malignant tumors.

27 Nov 2018

FDA grants accelerated approval to oncology drug for treatment of key genetic driver of cancer

The U.S. Food and Drug Administration today granted accelerated approval to Vitrakvi (larotrectinib), a treatment for adult and pediatric patients whose cancers have a specific genetic feature (biomarker).

27 Nov 2018

Colorectal cancer screening reduces need for intense treatments among male patients

While screening for colorectal cancer did not, so far, reduce mortality, it did reduce the need for chemotherapy and emergency surgeries among male patients, shows a recent Finnish study.

21 Nov 2018

UH pharmaceutical scientist developing new drug to treat children with rare genetic disorder

A University of Houston pharmaceutical scientist is developing a new drug which could bring relief to children suffering with Familial Adenomatous Polyposis, a rare genetic disorder characterized by hundreds - if not thousands - of colorectal polyps.

21 Nov 2018

Purified omega-3 and aspirin reduce pre-cancerous bowel polyps, shows study

Both aspirin and a purified omega-3, called EPA, reduce the number of pre-cancerous polyps in patients found to be at high risk of developing bowel cancer, according to new research.

20 Nov 2018

New report highlights key focus areas to help cancer screening realize its full potential

Cancer screening has contributed substantially to reduced incidence, morbidity, and mortality, but issues like access and quality care and have kept screening from fulfilling its full potential, according to a new report.

19 Nov 2018

Scientists equip new virus that kills carcinoma cells with protein

Scientists have equipped a virus that kills carcinoma cells with a protein so it can also target and kill adjacent cells that are tricked into shielding the cancer from the immune system.

19 Nov 2018

Inhibition of prostaglandin E2 enhances ability to combat infectious colitis

The treatment of intestinal infections caused by some strains of the bacterium Escherichia coli, present in unsanitized or contaminated foods, may have a new ally.

15 Nov 2018

Cranberry consumption modifies impact of animal-based diet on gut health

In a recently published feeding trial in The Journal of Nutritional Biochemistry, scientists investigated the potential protective effect of cranberries on the gut microbiome with an animal-based diet.

13 Nov 2018

Fecal microbiota transplantation effective against ICI-associated colitis

For the first time, transplanting gut bacteria from healthy donors was used to successfully treat patients suffering from severe colitis caused by treatment with immune checkpoint inhibitors.

12 Nov 2018

Regenstrief scientist calls for precision surveillance for colon cancer screening

The interval at which an individual undergoes a repeat colonoscopy because of previous pre-cancerous polyps -- a practice known as "surveillance" -- should be tailored to the individual and not simply be determined by the results of prior colonoscopies, according to Regenstrief Institute research scientist Thomas F. Imperiale, M.D.

8 Nov 2018

MCG selected as designated laboratory for NCI-MATCH trial

The Georgia Esoteric and Molecular Laboratory at the Medical College of Georgia at Augusta University has been selected as a designated laboratory for the National Cancer Institute's Molecular Analysis for Therapy Choice, or MATCH trial, which is assessing the effectiveness of targeting cancer-causing gene changes rather than cancer type.

1 Nov 2018

University of Missouri receives NIH grant for continued operation of NSRRC

The University of Missouri has received $7.229 million for continued operation of the National Swine Resource and Research Center.

31 Oct 2018

Colon News and Research

Exercise may reduce colorectal cancer risk after weight loss

Disrupted biological clock can contribute to onset of diseases, USC study shows

Novel personalized medicine tool for assessing inherited colorectal cancer syndrome risk developed

Study: Patients with cancer have worse outcomes after heart procedure

Researchers reveal how some cancers trick healthy cells into protecting tumors

Restricting cancer metabolism could make oncolytic viruses more effective at attacking tumors

CytoReason announces publication of new model for translating data from mouse models to human disease

Researchers find link between inflammatory markers and tumor aggressiveness

FDA grants accelerated approval to oncology drug for treatment of key genetic driver of cancer

Colorectal cancer screening reduces need for intense treatments among male patients

UH pharmaceutical scientist developing new drug to treat children with rare genetic disorder

Purified omega-3 and aspirin reduce pre-cancerous bowel polyps, shows study

New report highlights key focus areas to help cancer screening realize its full potential

Scientists equip new virus that kills carcinoma cells with protein

Inhibition of prostaglandin E2 enhances ability to combat infectious colitis

Cranberry consumption modifies impact of animal-based diet on gut health

Fecal microbiota transplantation effective against ICI-associated colitis

Regenstrief scientist calls for precision surveillance for colon cancer screening

MCG selected as designated laboratory for NCI-MATCH trial

University of Missouri receives NIH grant for continued operation of NSRRC

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News